Jump to Main Content

FDA Alerts

FDA Approves First Drug for Prophylaxis of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients

The Food and Drug Administration approved Prevymis (letermovir) tablets and injection, the first drug indicated to help prevent CMV (cytomegalovirus) infection and disease in adults who have been exposed to CMV and have received an allogeneic hematopoietic stem cell (bone marrow) transplant.